These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. About invasive cervical cancer: a French population based study between 1998 and 2010. Lorin L, Bertaut A, Hudry D, Beltjens F, Roignot P, Bone-Lepinoy MC, Douvier S, Arveux P. Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674 [Abstract] [Full Text] [Related]
28. [Evaluation of diagnostic methods and characteristics of patients operated on for cervical cancer in Lithuania, 1998-2000]. el-Aawar B. Medicina (Kaunas); 2002 Aug; 38(6):597-610. PubMed ID: 12474666 [Abstract] [Full Text] [Related]
29. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy]. Ma R, Zhang H, Zou L, Qu Y. Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610 [Abstract] [Full Text] [Related]
31. Cervical cancer in women under 25 years of age and outside the screening age: Diagnosis profile and long-term outcomes. Teixeira JC, Santos DZ, Campos CS, Vale DB, Bragança JF, Zeferino LC. Int J Gynaecol Obstet; 2021 Jul; 154(1):150-156. PubMed ID: 33341962 [Abstract] [Full Text] [Related]
32. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy. Chen JL, Huang CY, Huang YS, Chen RJ, Wang CW, Chen YH, Cheng JC, Cheng AL, Kuo SH. Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257 [Abstract] [Full Text] [Related]
35. Clinical behaviors and outcomes for adenocarcinoma or adenosquamous carcinoma of cervix treated by radical hysterectomy and adjuvant radiotherapy or chemoradiotherapy. Huang YT, Wang CC, Tsai CS, Lai CH, Chang TC, Chou HH, Lee SP, Hong JH. Int J Radiat Oncol Biol Phys; 2012 Oct 01; 84(2):420-7. PubMed ID: 22365621 [Abstract] [Full Text] [Related]
36. Evaluating the Role of F-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Scanning in the Staging of Patients With Stage IIIB Cervical Carcinoma and the Impact on Treatment Decisions. Morkel M, Ellmann A, Warwick J, Simonds H. Int J Gynecol Cancer; 2018 Feb 01; 28(2):379-384. PubMed ID: 29324535 [Abstract] [Full Text] [Related]
37. The incidence, treatment and prognosis of cervical carcinoma in young women: a retrospective analysis of 4,975 cases in Japan. Kokawa K, Takekida S, Kamiura S, Kita M, Enomoto T, Kawaguchi R, Saito J, Horie A, Umesaki N. Eur J Gynaecol Oncol; 2010 Feb 01; 31(1):37-43. PubMed ID: 20349779 [Abstract] [Full Text] [Related]
38. Evaluation of causes of increased incidence of cervical cancer in Slovenia. Smrkolj S, Rakar S, Mozina A, Erzen M. Eur J Obstet Gynecol Reprod Biol; 2004 Dec 01; 117(2):213-21. PubMed ID: 15541860 [Abstract] [Full Text] [Related]
39. ACOG practice bulletin. Diagnosis and treatment of cervical carcinomas. Number 35, May 2002. American College of Obstetricians and Gynecologists. American College of Obstetricians and Gynecologists.. Int J Gynaecol Obstet; 2002 Jul 01; 78(1):79-91. PubMed ID: 12197489 [Abstract] [Full Text] [Related]